Stay updated on DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial

Sign up to get notified when there's something new on the DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4, reflecting a newer build/version of the page.
    Difference
    0.0%
    Check dated 2026-05-15T05:17:12.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.5.2 to v3.5.3. This indicates a minor release update to the page, with no substantive content changes evident.
    Difference
    0.0%
    Check dated 2026-04-30T17:59:19.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No study content or essential functionality was altered.
    Difference
    0.0%
    Check dated 2026-04-16T10:59:12.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page revision was updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-18T19:40:24.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3 and removes the previous Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T18:19:27.000Z thumbnail image
  9. Check
    108 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the government funding lapse notice and Revision: v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-11T02:31:28.000Z thumbnail image

Stay in the know with updates to DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial page.